OP0238-HPR: effectiveness of digital patient education programme for RA self-management Intervention led to improved self-efficacy, w minor improved RA knowledge, #HealthLiteracy & #QoL ➡️such interventions may improve self-management & lower health costs @RheumNow #EULAR2024

Some of the great questions in ICI-induced irAE pathophysiology, from the great Andy Cope @KingsCollegeLon #EULAR2024 @RheumNow https://t.co/aHDqnvhboo

• https://twitter.com/drdavidliew/status/1801916138072498371/photo/1

🙏🏻I am so grateful for @RheumNow's coverage of our research about radiomics in AxSpA ⭐️I believe radiomics has potential and hope it will become a thing in Rheumatology 👇🏻Here is my interview with @bella_mehta about POS 0236 which I presented at #EULAR2024 https://t.co/yvD9yCIzQ8

• Potential Of Radiomics To Predict TNF Ther | RheumNow

DEFINING OVERALL AND SEX-SPECIFIC BASDAI CUT-OFFS FOR DISEASE ACTIVITY STATES IN AXIAL SPONDYLARTHRITIS – RESULTS FROM THE EUROSPA COLLABORATION - more data to stratify for gender at baseline all future AxSpA trials @RheumNow #EULAR2024 https://t.co/nQwCDOxN8R

• https://twitter.com/drpnash/status/1801914600822071787/photo/1

#EULAR2024 #scleroderma #recommend’ns @eular_org #lung #ILD Divide in to #prevention vs #Rx #Immune #suppressive #Rx vs #antifibrotic My thoughts -?other Rx as ⬆️MR Likely all effective early #Rx of skin Improve Risk of #progression▶️ILD @EUSTAR_org @RheumNow https://t.co/4wJyeSEHv3

• https://twitter.com/Janetbirdope/status/1801909893487608243/photo/1
• https://twitter.com/Janetbirdope/status/1801909893487608243/photo/1

EFFICACY AND SAFETY OF IXEKIZUMAB IN CHILDREN WITH ACTIVE JUVENILE PSORIATIC ARTHRITIS AND ENTHESITIS RELATED ARTHRITIS (COSPIRIT-JIA): 16-WEEK RESULTS OF A MULTICENTRE, RANDOMISED, OPEN-LABEL STUDY - IL17 effective & safe in JIA @RheumNow #EULAR2024

Izokibep Ph2b/3 RCT PsA 340+ Primary endpoint ACR50 wk 16 IZO 160 mg Q2W 43% IZO 160 mg QW 40% PBO 15% Effect early as wk 4 PASI100 IZO Q2W 47% IZO QW 51% PBO 12% Safety profile similar to IL-17i @RheumNow #EULAR2024 LBA0005 https://t.co/vWRQ1ECrAX

• https://twitter.com/AurelieRheumo/status/1801901877417636106/photo/1

ReMonit RCT 240+ axSPA pts Remote Monitoring & Patient-initiated Care NON INFERIOR Usual care for ASDAS <2.1 over 18mo No diff between Patient-initiated Care & Remote Monitoring No diff in disease activity & function >90% satisfaction in all arms #EULAR2024 @RheumNow LB0004 https://t.co/mLTS5fLXFN

• https://twitter.com/AurelieRheumo/status/1801898253610365272/photo/1

This is critical. If we're going to try and treat pre-RA, it's all about picking the right patient: - avoid exposing future non-responders to harm - modify the course of disease in those who will benefit Fantastic that @eular_org are addressing this need. #EULAR2024 @RheumNow https://t.co/9pF33eLbuZ

• https://twitter.com/Stiddyo/status/1801892223312617572

Scleroderma: the present, and the future. #EULAR2024 @RheumNow https://t.co/v5vxfmM4i3

• https://twitter.com/drdavidliew/status/1801896558184845375/photo/1

Open-label extension of BE MOBILE 2 Ph3 Bimekizumab in r-axSpA 200 pts w/ 2yr radiographic outcome 85.3% non progressors (mSASSS CfB ≤0.5) 92.1% (mSASSS CfB <2) 83.1% had existing structural damage (mSASSS ≥2) at BL #EULAR2024 @RheumNow Abst LBA0003 https://t.co/DQeiXHDnSF

• https://twitter.com/AurelieRheumo/status/1801896517608878481/photo/1

PRO-SPIRIT 1100+ PsA Observational study IXE i= TNFi and JAKi for improving joint dis activity in IXE higher previous b/tsDMARD & less concomitant csDMARDs IXE & IL-17Ai = faster improvement cDAPSA than IL-12/23i or IL-23i Abst LBA0002 #EULAR2024 @RheumNow https://t.co/8DbtCQECNN

• https://twitter.com/AurelieRheumo/status/1801895455757852889/photo/1

IL-6 Immunotherapy for knee OA PPV-06 FTIH Phase 1 Is it safe? looks it, no serious AES, 6mo follow up Is it immunogenic? apparently so, IL-6 Ab & neutralizing Ab Does it work? will have to wait for Phase 2 Somehow bold knowing TCZ did not work in hand OA AbstLBA0011 #EULAR2024… https://t.co/pO0Dx3jl8E https://t.co/p1zYUtgFoM

• https://twitter.com/i/web/status/1801894324684157080
• https://twitter.com/AurelieRheumo/status/1801894324684157080/photo/1
• https://twitter.com/AurelieRheumo/status/1801894324684157080/photo/1

#Scleroderma updated #EULAR2024 #recommendations @eular_org SKIN Are they good enough? Great work by task force @EUSTAR_org Do we alter initial Rx if v high mRSS? Ex #MMF not much improvement on skin vs #RTX #Cyclo Or combo Rx? We need to improve #SoC ?CAR-T ? RCT @RheumNow https://t.co/WhEzDdjVeu

• https://twitter.com/Janetbirdope/status/1801893420929040497/photo/1

#Scleroderma updated #EULAR2024 #recommendations @eular_org Are they good enough? Great work by task force @EUSTAR_org #PAH my thoughts Where does #sotaracept in #PAH fit in Not mentioned ?#selexipag before #epoprostenol For sure there is country variant @RheumNow https://t.co/3dJ6eusSkU

• https://twitter.com/Janetbirdope/status/1801891493726106028/photo/1
• https://twitter.com/Janetbirdope/status/1801891493726106028/photo/1